Published in J Virol on May 01, 1986
Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J Virol (1989) 1.95
The avian erythroblastosis virus erbA oncogene encodes a DNA-binding protein exhibiting distinct nuclear and cytoplasmic subcellular localizations. J Virol (1988) 1.13
Domains of beta-tubulin essential for conserved functions in vivo. Mol Cell Biol (1987) 1.10
Dissection of functional domains of adenovirus DNA polymerase by linker-insertion mutagenesis. Proc Natl Acad Sci U S A (1989) 1.02
Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol (1991) 0.95
Induction of proliferation of neuroretina cells by long terminal repeat activation of the carboxy-terminal part of c-mil. Mol Cell Biol (1987) 0.94
Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis. Mol Cell Biol (1987) 0.91
Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene. Mol Cell Biol (1988) 0.89
The amino-terminal 14 amino acids of v-src can functionally replace the extracellular and transmembrane domains of v-erbB. Mol Cell Biol (1991) 0.88
Analysis of the role of the Shc and Grb2 proteins in signal transduction by the v-ErbB protein. Mol Cell Biol (1994) 0.87
Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics. Mol Cell Biol (1992) 0.83
Creation of a chimeric oncogene: analysis of the biochemical and biological properties of v-erbB/src fusion polypeptide. J Virol (1987) 0.83
Mapping by in vitro constructs of the P100gag-mil region, accounting for induction of chicken neuroretina cell proliferation. J Virol (1988) 0.79
Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus. J Virol (1990) 0.78
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (1984) 14.21
Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (1982) 7.22
Mapping of closed circular DNAs by cleavage with restriction endonucleases and calibration by agarose gel electrophoresis. Proc Natl Acad Sci U S A (1977) 7.09
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (1985) 6.23
Autophosphorylation sites on the epidermal growth factor receptor. Nature (1984) 5.11
Growth factors: mechanism of action and relation to oncogenes. Cell (1984) 4.80
Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus. Nature (1982) 4.33
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature (1984) 4.27
Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell (1982) 4.06
Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus. Nature (1981) 4.05
Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell (1985) 4.02
The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell (1983) 3.82
Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science (1984) 3.06
Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes. Cell (1983) 3.03
A general method for inserting specific DNA sequences into cloning vehicles. Gene (1976) 3.02
Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells. J Virol (1980) 3.01
c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell (1985) 3.00
Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell (1982) 2.78
Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. Virology (1983) 2.53
Identification and characterization of the avian erythroblastosis virus erbB gene product as a membrane glycoprotein. Cell (1983) 2.44
Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production. Cell (1974) 2.31
Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vitro studies with avian erythroblastosis virus. Virology (1976) 2.28
Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses. Cell (1978) 2.23
One and two codon insertion mutants of bacteriophage f1. Mol Gen Genet (1981) 2.20
Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell (1985) 2.16
Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell (1984) 2.12
Temperature-sensitive mutant of avian erythroblastosis virus suggests a block of differentiation as mechanism of leukaemogenesis. Nature (1978) 2.06
A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell (1983) 1.95
The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62
Primary structure of v-raf: relatedness to the src family of oncogenes. Science (1984) 1.56
Temperature-sensitive mutants of avian erythroblastosis virus: surface expression of the erbB product correlates with transformation. Cell (1984) 1.43
Identification of a form of the avian erythroblastosis virus erb-B gene product at the cell surface. Nature (1984) 1.40
Site-specific mutagenesis of avian erythroblastosis virus: v-erb-A is not required for transformation of fibroblasts. Virology (1983) 1.40
Proteins specified by avian erythroblastosis virus: coding region localization and identification of a previously undetected erb-B polypeptide. Proc Natl Acad Sci U S A (1982) 1.36
Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products. Nature (1983) 1.23
The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A (1984) 1.23
Heterogeneity of strain R avian (erythroblastosis) virus. Cancer Res (1970) 1.22
Subcellular localization of the v-erb-B protein, the product of a transforming gene of avian erythroblastosis virus. Virology (1984) 1.20
Isolation and characterization of four new temperature-sensitive mutants of avian erythroblastosis virus (AEV). Virology (1982) 1.15
Amino acid sequence at the ATP-binding site of cGMP-dependent protein kinase. J Biol Chem (1982) 1.07
Modification of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity labels related to peptide substrates. J Biol Chem (1982) 1.04
Transformation parameters of chicken embryo fibroblasts infected with the ts34 mutant of avian erythroblastosis virus. Virology (1980) 0.85
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72
FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (1998) 5.29
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing. Nature (1996) 3.81
Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity (2000) 3.29
SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.75
Site-specific mutagenesis of avian erythroblastosis virus: erb-B is required for oncogenicity. Virology (1983) 2.53
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics (2000) 2.31
Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest (1994) 2.31
Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol (1996) 2.02
Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer (1993) 1.99
Experience with vesicoureteral reflux in children: clinical characteristics. J Urol (1997) 1.87
Effects of a gastrin-like pentapeptide (I.C.I. 50,123) on stomach and pancreas. Lancet (1966) 1.85
The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry (2006) 1.64
The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62
Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem (1998) 1.61
The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol (2000) 1.60
Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol (1997) 1.60
Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol (1994) 1.59
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity (1999) 1.56
Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol (1998) 1.51
Effects of prognosis, perceived benefit, and decision style on decision making and critical care on decision making in critical care. Crit Care Med (1999) 1.46
Scanning electron microscopy of Chilomastix mesnili (Wenyon 1910) Alexieieff, 1912. Parasitol Res (2000) 1.41
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Proteins specified by avian erythroblastosis virus: coding region localization and identification of a previously undetected erb-B polypeptide. Proc Natl Acad Sci U S A (1982) 1.36
The structure and synthesis of influenza virus phosphoproteins. J Biol Chem (1981) 1.27
Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene (2006) 1.26
A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia (2008) 1.24
Phosphorylated protein component present in influenza virions. J Virol (1977) 1.24
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A (1984) 1.23
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
Living with a chronic illness: Chinese-Canadian and Euro-Canadian women with diabetes--exploring factors that influence management. Soc Sci Med (1995) 1.20
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea. Lancet (1983) 1.20
Subcellular localization of the v-erb-B protein, the product of a transforming gene of avian erythroblastosis virus. Virology (1984) 1.20
Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice. Arthritis Rheum (1975) 1.19
Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol (1998) 1.16
Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood (2000) 1.15
Reconstitution of retinoid X receptor function and combinatorial regulation of other nuclear hormone receptors in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1993) 1.13
The avian erythroblastosis virus erbA oncogene encodes a DNA-binding protein exhibiting distinct nuclear and cytoplasmic subcellular localizations. J Virol (1988) 1.13
v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell (1991) 1.11
Resolution rates of low grade vesicoureteral reflux stratified by patient age at presentation. J Urol (1997) 1.10
Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease. Biochemistry (1990) 1.09
Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain. Mol Cell Biol (1993) 1.08
Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A (1978) 1.08
Evaluation of the semi-automated Autosperm semen analysis system. II. Comparison with conventional method, time-exposure photomicrography, and automated CellSoft system. Fertil Steril (1990) 1.08
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer (1998) 1.08
Cross-sectional study of semen parameters in a large group of normal Chinese men. Int J Androl (1985) 1.07
Acute cholangitis--predictive factors for emergency ERCP. Aliment Pharmacol Ther (2001) 1.05
Cooperative formation of high-order oligomers by retinoid X receptors: an unexpected mode of DNA recognition. Proc Natl Acad Sci U S A (1995) 1.05
The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol Cell Biol (1993) 1.04
Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol (2000) 1.03
Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem (1999) 1.02
A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol (1997) 1.02
Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. Mol Endocrinol (1998) 1.00
v-erbA and citral reduce the teratogenic effects of all-trans retinoic acid and retinol, respectively, in Xenopus embryogenesis. Development (1993) 0.99
DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. Cell Growth Differ (2001) 0.99
Plasticity of tetramer formation by retinoid X receptors. An alternative paradigm for DNA recognition. J Biol Chem (1997) 0.97
Transmembrane domain of the AEV erb B oncogene protein is not required for partial manifestation of the transformed phenotype. Virology (1987) 0.97
Surgery of the salivary glands. Otolaryngol Clin North Am (1999) 0.96
Retained common bile duct stones: a comparison between biliary stenting and complete clearance of stones by electrohydraulic lithotripsy. Aliment Pharmacol Ther (2003) 0.96
Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus. J Virol (1990) 0.96
DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants. J Biol Chem (1996) 0.95
Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia. Mol Cell Biol (2001) 0.95
p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene (1994) 0.95
Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol (1991) 0.95
V-erbA and c-erbA proteins enhance transcriptional activation by c-jun. Oncogene (1992) 0.94
The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol Cell Biochem (2001) 0.94
Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor. J Biol Chem (2001) 0.93
Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Mol Cell Endocrinol (2000) 0.93
Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur J Surg Oncol (2009) 0.92
Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen. Am J Clin Pathol (1995) 0.92
Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and older. Aliment Pharmacol Ther (2004) 0.91
Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene (2009) 0.91
Orientation of the v-erb-B gene product in the plasma membrane. Mol Cell Biol (1986) 0.90
Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users. Health Matrix Clevel (2001) 0.89
Vagus nerves and baroreceptor control of ventricular performance. Circ Res (1966) 0.89
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer (2009) 0.88
Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors. Am J Gastroenterol (1997) 0.88
An analysis of social and economic factors associated with followup of patients with vesicoureteral reflux. J Urol (1996) 0.87
Mapping of functional domains within the v-erb A oncogene protein: the remnants of the hormone binding domain play multiple, vital roles in protein action. Oncogene (1990) 0.86
Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J Biol Chem (1998) 0.86
Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys (1998) 0.86
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut (1985) 0.85
Diagnostic value of sperm function tests and routine semen analyses in fertile and infertile men. J Androl (1989) 0.85
p53 protein detected by immunohistochemical staining is not always mutant. Dis Markers (1993) 0.85
Effect of cyclic adenosine 3',5'-monophosphate antagonists on endotoxin-induced inhibition of human neutrophil chemotaxis. Infect Immun (1979) 0.84
On chronic illness: immigrant women in Canada's work force--a feminist perspective. Can J Nurs Res (1993) 0.84
Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol (1999) 0.84
Duodenal ulcer healing by separate reduction of postprandial and nocturnal acid secretions have different pathophysiology. Gut (1985) 0.83
Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction. Mol Endocrinol (2001) 0.83
Mutagenesis of the avian erythroblastosis virus erbB coding region: an intact extracellular domain is not required for oncogenic transformation. J Virol (1986) 0.83
Creation of a chimeric oncogene: analysis of the biochemical and biological properties of v-erbB/src fusion polypeptide. J Virol (1987) 0.83
Changes in diagnostic decision-making after a computerized decision support consultation based on perceptions of need and helpfulness: a preliminary report. Proc AMIA Annu Fall Symp (1997) 0.83
Sibling reflux: a dual center retrospective study. J Urol (1996) 0.82
Protein phosphorylation in isolated plasma membranes and postsynaptic junctional structures from brain synapses. Neuroscience (1979) 0.82
Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae. Oncogene (1993) 0.82
Purified recombinant EBV desoxyribonuclease in serological diagnosis of nasopharyngeal carcinoma. Int J Cancer (1996) 0.81